Cargando…
Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection
BACKGROUND: Spinal cord injury (SCI) is a severe neurological disorder with many disabling consequences, including persistent neuropathic pain, which develops in about 40 % of SCI patients and is induced and sustained by excessive and uncontrolled spinal neuroinflammation. Here, we have evaluated th...
Autores principales: | Martini, Alessandra Cadete, Berta, Temugin, Forner, Stefânia, Chen, Gang, Bento, Allisson Freire, Ji, Ru-Rong, Rae, Giles Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826542/ https://www.ncbi.nlm.nih.gov/pubmed/27059991 http://dx.doi.org/10.1186/s12974-016-0540-8 |
Ejemplares similares
-
Neuroprotective Effects of Lipoxin A4 in Central Nervous System Pathologies
por: Martini, Alessandra Cadete, et al.
Publicado: (2014) -
Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury
por: Suter, Marc R, et al.
Publicado: (2009) -
Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord
por: Zhang, Ting-Ting, et al.
Publicado: (2018) -
Effects of norepinephrine on microglial neuroinflammation and neuropathic pain
por: Zou, He‐Lin, et al.
Publicado: (2021) -
OECs transplantation results in neuropathic pain associated with BDNF regulating ERK activity in rats following cord hemisection
por: Lang, Bing-Chen, et al.
Publicado: (2013)